Drug Shortage Report for CEFTRIAXONE INJECTION, USP

Last updated on 2026-02-23

Report ID 276005
Drug Identification Number 02499738
Brand name CEFTRIAXONE INJECTION, USP
Common or Proper name Ceftriaxone Injection USP 2000 mg / 50 mL
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 2000MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2000 mg / 50 mL
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2026-01-19
Actual start date 2026-01-19
Estimated end date 2026-02-20
Actual end date 2026-02-20
Shortage status Resolved
Updated date 2026-02-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2026-02-23 French Compare
v11 2026-02-23 English Compare
v10 2026-02-13 French Compare
v9 2026-02-13 English Compare
v8 2026-02-03 French Compare
v7 2026-02-03 English Compare
v6 2026-02-03 English Compare
v5 2026-02-03 French Compare
v4 2026-02-03 English Compare
v3 2026-01-14 French Compare
v2 2026-01-14 English Compare
v1 2026-01-14 English Compare

Showing 1 to 12 of 12